Search ARM

Cellaïon is a new company created in 2021, using cell signaling technology to treat life threatening liver diseases. The company is currently in phase IIB clinical development, actively recruiting, in Acute on Chronic Liver Failure.

Contact Cellaïon
+32 10 39 43 31
Visit Website